CBS 2019
CBSMD教育中心
中 文

DAPT Duration

Abstract

Recommended Article

Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey A randomized comparison of Coronary Stents according to Short or Prolonged durations of Dual Antiplatelet Therapy in patients with Acute Coronary Syndromes: a pre-specified analysis of the SMART-DATE trial The optimal duration of dual antiplatelet therapy after coronary stent implantation: to go too far is as bad as to fall short Ticagrelor with or without Aspirin in High-Risk Patients after PCI A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study Efficacy and Safety of Ticagrelor Monotherapy in Patients Undergoing Multivessel PCI Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.

Original Research2009 May;2(5):428-34.

JOURNAL:JACC Cardiovasc Interv. Article Link

A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis

Liu X, Doi H, Maehara A et al. Keywords: DES; thrombosis; IVUS; in-stent restenosis

FULL TEXT PDF